Literature DB >> 33010254

Molecular mechanisms of KDM5A in cellular functions: Facets during development and disease.

R Kirtana1, Soumen Manna1, Samir Kumar Patra2.   

Abstract

Gene expression is influenced at many layers by a fine-tuned crosstalk between multiple extrinsic signalling pathways and intrinsic regulatory molecules that respond to environmental stimuli. Epigenetic modifiers like DNA methyltransferases, histone modifying enzymes and chromatin remodellers are reported to act as triggering factors in many scenarios by exhibiting their control over most of the cellular processes. These epigenetic players can either directly regulate gene expression or interact with some effector molecules that harmonize the expression of downstream genes. One such epigenetic regulator which exhibits multifaceted regulation over gene expression is KDM5A. It is classically a transcriptional repressor acting as H3K4me3 demethylase, but also is reported to act as an activator in many contexts either by loss of activity due to inhibition manifested by other interacting proteins or by downregulating the negative players of a given physiological process thereby escalating the framework. Through this review, we draw attention to the remarkable modes of functioning laid by KDM5A on transcriptional and translational processes, affecting gene expression during differentiation and development and finally summing up on role in disease causation (Fig. 1). We also shed light on different orthologs of KDM5A and their organism specific roles, along with comparison of the sequence similarity to extrapolate some unanswered questions about this protein.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Embryonic development; Epigenetic functions; Genomic stability; H3K4me3 modification; Histone demethylase; KDM5A; KDM5A phylogeny

Year:  2020        PMID: 33010254     DOI: 10.1016/j.yexcr.2020.112314

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner.

Authors:  Yuanyuan Mi; Lifeng Zhang; Chuanyu Sun; Yanyan Feng; Jian Sun; Jun Wang; Dongjie Yang; Xiaowei Qi; Hongyuan Wan; Guowei Xia; Sheng Wu; Lijie Zhu
Journal:  J Cell Commun Signal       Date:  2022-05-18       Impact factor: 5.782

2.  Transcriptomic and ChIP-seq Integrative Analysis Identifies KDM5A-Target Genes in Cardiac Fibroblasts.

Authors:  Yiyao Jiang; Xu Zhang; Ting Wei; Xianjie Qi; Isah Amir Abba; Nana Zhang; Yao Chen; Ran Wang; Chao Shi
Journal:  Front Cardiovasc Med       Date:  2022-07-01

Review 3.  The emerging role of KDM5A in human cancer.

Authors:  Guan-Jun Yang; Ming-Hui Zhu; Xin-Jiang Lu; Yan-Jun Liu; Jian-Fei Lu; Chung-Hang Leung; Dik-Lung Ma; Jiong Chen
Journal:  J Hematol Oncol       Date:  2021-02-17       Impact factor: 17.388

4.  Differential microRNA Expression in USP8-Mutated and Wild-Type Corticotroph Pituitary Tumors Reflect the Difference in Protein Ubiquitination Processes.

Authors:  Mateusz Bujko; Paulina Kober; Joanna Boresowicz; Natalia Rusetska; Natalia Zeber-Lubecka; Agnieszka Paziewska; Monika Pekul; Grzegorz Zielinski; Andrzej Styk; Jacek Kunicki; Jerzy Ostrowski; Janusz A Siedlecki; Maria Maksymowicz
Journal:  J Clin Med       Date:  2021-01-20       Impact factor: 4.241

5.  Genome-Wide Association Study of 2,093 Cases With Idiopathic Polyneuropathy and 445,256 Controls Identifies First Susceptibility Loci.

Authors:  Bendik S Winsvold; Ioannis Kitsos; Laurent F Thomas; Anne Heidi Skogholt; Maiken E Gabrielsen; John-Anker Zwart; Kristian Bernhard Nilsen
Journal:  Front Neurol       Date:  2021-12-17       Impact factor: 4.003

6.  Altered genome-wide hippocampal gene expression profiles following early life lead exposure and their potential for reversal by environmental enrichment.

Authors:  G Singh; V Singh; T Kim; A Ertel; W Fu; J S Schneider
Journal:  Sci Rep       Date:  2022-07-25       Impact factor: 4.996

Review 7.  The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies.

Authors:  Hans Felix Staehle; Heike Luise Pahl; Jonas Samuel Jutzi
Journal:  Biomolecules       Date:  2021-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.